The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure.
A multi-site, open-labeled clinical trial was conducted to evaluate the ease of use and acceptance of a newly developed medication cap with a memory aid (C Cap Compliance Cap, Allergan, Inc.) and its effect on patient compliance and intraocular pressure. One-hundred-twenty-two patients with glaucoma or ocular hypertension received their prescribed eye drops in bottles with the compliance cap. Overall, 83% of the patients found the compliance cap very easy to use. By the end of the study, significantly more patients (67%) claimed 100% compliance than prior to using the compliance cap (41%). An overall drop in intraocular pressure of 0.8 mm Hg was seen. However, in a subset of patients who reported an increase in compliance, mean intraocular pressure decreased from baseline by 1.7 mm Hg. The results of this study suggest that the compliance cap helps patients with glaucoma or ocular hypertension remember to take their medication as prescribed.
Jules Stein Eye Institute, UCLA School of Medicine.
J S
JS
Chang
D A
DA
Lee
G
G
Petursson
G
G
Spaeth
T J
TJ
Zimmerman
H D
HD
Hoskins
R
R
Mills
R
R
Brown
M
M
Kass
J
J
Lue
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004348:Drug Labeling / Q000379:methods; D004837:Epinephrine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy*; D010349:Patient Compliance; D017060:Patient Satisfaction; D010862:Pilocarpine / Q000008:administration & dosage; D011446:Prospective Studies; D017010:Reminder Systems; D011795:Surveys and Questionnaires
D010862:Pilocarpine; C015173:dipivefrin; D004837:Epinephrine